KEY PUBLICATIONS
Published Peer-Reviewed Papers
DOES ADJUNCTIVE UNDER-FLAP CXL REDUCE REGRESSION FOR HYPEROPIC LASIK?
2022
Wallerstein A, Gauvin M. J Refract Surg. 2022. In press shortly.
POSTERIOR CORNEAL ASTIGMATISM DOES NOT INFLUENCE MANIFEST-TREATED TOPOGRAPHY-GUIDED LASIK OUTCOMES
2022
Wallerstein A, Gauvin M. J Refract Surg. 2022. In press shortly.
DOES PHORCIDES SOFTWARE YIELD INFERIOR TOPOGRAPHY-GUIDED LASIK ACCURACY VERSUS TARGETING THE MANIFEST ASTIGMATISM?
2022
Wallerstein A, Gauvin M. J Refract Surg. 2022;38(11):750-751
COMMENT ON: CLINICAL AND REFRACTIVE OUTCOMES AFTER TOPOGRAPHY-GUIDED REFRACTIVE SURGERY PLANNED USING SURGERY PLANNING SOFTWARE
2022
Wallerstein A, Gauvin M. J Cataract Refract Surg. 2022. In press shortly.
COMMENT ON: CLINICAL RESULTS OF TOPOGRAPHY-GUIDED LASER-ASSISTED IN SITU KERATOMILEUSIS USING THE ANTERIOR CORNEAL ASTIGMATISM AXIS AND MANIFEST REFRACTIVE ASTIGMATISM AXIS
2022
Wallerstein A, Gauvin M. Graefes Arch Clin Exp Ophthalmol. 2022. Online ahead of print.
THREE YEAR OUTCOMES OF UNDER-FLAP STROMAL BED CXL FOR EARLY POST-LASIK ECTASIA
2022
Wallerstein A, Gauvin M, Rocha G, Sison S, Korban S, Cohen M. J Refract Surg. 2022;38(8):511-519
HYPO-OSMOLAR ACCELERATED CXL ON RESULTANT SUB 400UM TOPOGRAPHY GUIDED EXCIMER REGULARIZED KERATOCONUS CORNEAS
2022
Salimi A, Gauvin M, Harissi-Dagher M, Racine L, Cohen M, Wallerstein A. J Cat Refract Surg. 2022. Publish Ahead of Print.
ASTIGMATISM TREATMENT BIAS IN A TOPOGRAPHY-GUIDED VS WAVEFRONT-OPTIMIZED LASIK META-ANALYSIS
2022
Wallerstein A, Gauvin M. J Refract Surg. 2022;38(2):142-143.
LARGE AXIS DIFFERENCE BETWEEN TOPOGRAPHIC ANTERIOR CORNEAL ASTIGMATISM AND MANIFEST REFRACTIVE ASTIGMATISM: CAN TOPOGRAPHY-GUIDED LASIK TARGET THE MANIFEST AXIS?
2021
Wallerstein A, Gauvin M, QI SR, Cohen M. J Refract Surg. 2021;37(10):662-673.
DOES ANTERIOR CORNEAL COMA AFFECT MANIFEST ASTIGMATISM? VIRGIN HEALTHY CORNEAS DIFFER FROM TRAUMATICALLY, SURGICALLY, OR BIOMECHANICALLY INDUCED IRREGULAR CORNEAS WITH HIGH COMA
2021
Wallerstein A, Gauvin M. J Refract Surg. 2021;37(8):1-2.
THE PEARL-DGS FORMULA: THE DEVELOPMENT OF AN OPEN-SOURCE MACHINE LEARNING-BASED THICK IOL CALCULATION FORMULA
2021
Debellemanière G, Dubois M, Gauvin M, Wallerstein A, Brenner F, Radhika R, Saad A, Gatinel D. Am J Ophthalmol. 2021.
VECTOR ANALYSIS REVEALS THAT TOPOGRAPHY-GUIDED LASIK TARGETING THE MANIFEST REFRACTION (MR) IS SUPERIOR TO TOPOGRAPHY-MODIFIED REFRACTION (TMR) AND LAYER YOLKED REDUCTION OF ASTIGMATISM (LYRA)
2021
Wallerstein A, Gauvin M. Clin Ophthalmol. 2021;15:889–890.
KERATOCONUS FEATURES ON CORNEAL HIGHER-ORDER ABERRATION ABLATION MAPS: PROOF-OF-CONCEPT OF A NEW DIAGNOSTIC MODALITY
2021
Wallerstein A, Gauvin M, Mimouni M, Racine L, Salimi A, Cohen M. Clin Ophthalmol. 2021;15:623–633.
ERRATUM FOR “THE RELATIONSHIP BETWEEN PREOPERATIVE ANTERIOR CORNEAL HIGHER ORDER ABERRATIONS AND TOPOGRAPHY-GUIDED EXCIMER ABLATION DEPTH”
2021
Wallerstein A, Gauvin M, Cohen M. J Refract Surg. 2021;37(2).
DISAGREEMENT BETWEEN THEORETICAL AND ACTUAL PHORCIDES OUTCOMES: IS PHORCIDES INFERIOR TO TREATING ON THE MANIFEST REFRACTION?
2020
Wallerstein A, Gauvin M. Clin Ophthalmol. 2020;14:3829-3830.
IS PHORCIDES MORE LIKELY TO GIVE BETTER VISION THAN TREATING THE MANIFEST REFRACTION?
2020
Wallerstein A, Gauvin M. J Cat Refract Surg. 2020;46(10):1451-1452.
THE RELATIONSHIP BETWEEN ANTERIOR CORNEAL HIGHER-ORDER ABERRATIONS AND TOPOGRAPHY-GUIDED EXCIMER ABLATION DEPTH
2020
Wallerstein A, Gauvin M, Cohen M. J Refract Surg. 2020;36(8):506-510.
RE: ANG ET AL.: RANDOMIZED CLINICAL TRIAL COMPARING FEMTOSECOND LASIK AND SMALL INCISION LENTICULE EXTRACTION.
2020
Wallerstein A, Gauvin M. Ophthalmology.
2020;127:724-730.
EFFECT OF THE VECTORIAL DIFFERENCE BETWEEN MANIFEST REFRACTIVE ASTIGMATISM AND ANTERIOR CORNEAL ASTIGMATISM ON TOPOGRAPHY-GUIDED LASIK OUTCOMES
2020
Wallerstein A, Gauvin M, Qi SR, Cohen M. J Refract Surg. 2020;35(12):754-762.
REFRACTIVE, VISUAL, AND SUBJECTIVE QUALITY OF VISION OUTCOMES FOR VERY HIGH MYOPIA LASIK FROM −10.00 TO −13.50 DIOPTERS
2020
Wallerstein A, Kam JWK, Gauvin M, Adiguzel E, Bashour M, Kalevar A, Cohen M. BMC Ophthalmol. 2020;20(234):1-10.
TARGETING ANTERIOR CORNEAL ASTIGMATISM WITH TOPOGRAPHY-GUIDED ABLATION IGNORES OCULAR RESIDUAL ASTIGMATISM,
RESULTING IN INFERIOR OUTCOMES
2020
Wallerstein A, Gauvin M, Cohen M. J Refract Surg. 2020;36(1):63-65.
TOPOGRAPHY-GUIDED ABLATION TARGETING THE ANTERIOR CORNEAL ASTIGMATISM YIELDS INFERIOR OUTCOMES VS TARGETING THE MANIFEST REFRACTIVE ASTIGMATISM
2019
Wallerstein A, Gauvin M, Cohen M. J Refract Surg. 2019;35(12):815-816.
EFFECT OF ANTERIOR CORNEAL HIGHER-ORDER ABERRATION ABLATION DEPTH ON PRIMARY TOPOGRAPHY-GUIDED LASIK OUTCOMES
2019
Wallerstein A, Gauvin M, Cohen M. J Refract Surg. 2019;35(12):754-762.
COMMENT ON “UNDER-THE-FLAP CROSSLINKING AND LASIK IN EARLY ECTASIA WITH HYPEROPIC REFRACTIVE ERROR”
2019
Wallerstein A, Gauvin M, Cohen M. J of Ophthalmol. 2019;24986597.
TOPOGRAPHY-GUIDED EXCIMER
TREATMENT PLANNING: CONTRIBUTION OF ANTERIOR CORNEAL COMA TO OCULAR RESIDUAL ASTIGMATISM
2019
Wallerstein A, Gauvin M, McCammon, Cohen M. J Cataract Refract Surg. 2019;45(6):878-880.
PRIMARY TOPOGRAPHY-GUIDED LASIK: REFRACTIVE, VISUAL, AND SUBJECTIVE QUALITY OF VISION OUTCOMES FOR ASTIGMATISM ≥2.00 DIOPTERS
2019
Wallerstein A, Caron-Cantin M, Gauvin M, Adiguzel E, Cohen M. J Refract Surg. 2019;35(2):78-86.
PRIMARY TOPOGRAPHY-GUIDED LASIK: TREATING MANIFEST REFRACTIVE ASTIGMATISM
VERSUS TOPOGRAPHY-MEASURED ANTERIOR CORNEAL ASTIGMATISM
2019
Wallerstein A, Gauvin M, Qi SR, Bashour M, Cohen M. J Refract Surg. 2020;35(1):15-23.
AUTHORS' REPLY: WAVELIGHT® CONTOURA TOPOGRAPHY-GUIDED PLANNING
2018
Wallerstein A, Gauvin M, Cohen M. Clin Ophthalmol. 2018;12:2001-2004.
ASTIGMATIC: AN AUTOMATIC TOOL FOR STANDARD ASTIGMATISM VECTOR ANALYSIS
2018
Gauvin M, Wallerstein A. BMC Ophthalmol. 2018;18(255):1-7.
WAVELIGHT® CONTOURA TOPOGRAPHY-GUIDED PLANNING: CONTRIBUTION OF ANTERIOR CORNEAL HIGHER-ORDER ABERRATIONS AND POSTERIOR CORNEAL ASTIGMATISM TO MANIFEST REFRACTIVE ASTIGMATISM
2018
Wallerstein A, Gauvin M, Cohen M. Clin Ophthalmol. 2018;12:1423-1426.
MANAGEMENT OF POST-LASIK DRY EYE: A MULTICENTER RANDOMIZED COMPARISON OF A NEW MULTI-INGREDIENT ARTIFICIAL TEAR TO CARBOXYMETHYLCELLULOSE
2018
Wallerstein A, Jackson B, Chambers J, Moezzi A, Lin H, Simmons P. Clin Ophthalmol. 2018;12:839-848.
CLINICALLY SIGNIFICANT LASER IN SITU KERATOMILEUSIS FLAP STRIAE
2017
Wallerstein A, Gauvin M, Adiguzel E, Singh H, Gupta V, Harissi-Dagher M, Cohen M. J Cataract Refract Surg. 2017; 43:1523–1533.
UNDER-FLAP STROMAL BED CXL FOR EARLY POST-LASIK ECTASIA: A NOVEL TREATMENT TECHNIQUE
2016
Wallerstein A, Adiguzel E, Gauvin M, Mohammad-Shahi N, Cohen M. Clin Ophthalmol. 2017;11:1-8.